Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Myristoylated-peptidyl-recombinant Human CD59

EU orphan designation number: EU/3/02/114
Active ingredient: Myristoylated-peptidyl-recombinant Human CD59
Indication: Treatment of paroxysmal nocturnal haemoglubinuria
Sponsor: Orexo AB
Virdings Allé 32 A, SE-754 50 Uppsala, Svėrige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/09/2002 Centralised Orphan - Designation EMEA/OD/016/02 (2002)3402 of 11/09/2002
29/06/2007 Other procedure
30/09/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/016/02/T/01 (2008)5594 of 26/09/2008
03/03/2009 Centralised Orphan - Removal of orphan designation from Community Register